Page last updated: 2024-11-07

prunasin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

prunasin: cyanogenic glycoside; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119033
CHEMBL ID1778417
CHEBI ID17396
SCHEMBL ID377612
MeSH IDM0071193

Synonyms (39)

Synonym
(2r)-prunasin
14w4bpm5fb ,
5-17-07-00405 (beilstein handbook reference)
unii-14w4bpm5fb
(r)-alpha-(beta-d-glucopyranosyloxy)benzene-acetonitrile
CHEBI:17396 ,
(r)-mandelonitrile beta-d-glucopyranoside
(2r)-(beta-d-glucopyranosyloxy)(phenyl)acetonitrile
(r)-mandelonitrile beta-d-glucoside
d-prunasin
(r)-(beta-d-glucopyranosyloxy)phenylacetonitrile
benzeneacetonitrile, alpha-(beta-d-glucopyranosyloxy)-, (r)-
d-mandelonitrile-beta-d-glucoside
einecs 202-738-0
brn 0091509
(r)-prunasin
C00844
prunasin
99-18-3
(2r)-(beta-d-glucosyloxy)(phenyl)acetonitrile
(2r)-2-phenyl-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyacetonitrile
CHEMBL1778417
prunasin [inci]
benzeneacetonitrile, .alpha.-(.beta.-d-glucopyranosyloxy)-, (.alpha.r)-
benzeneacetonitrile, .alpha.-(.beta.-d-glucopyranosyloxy)-, (r)-
mandelonitrile glucoside d-form [mi]
mandelonitrile glucoside d-form
SCHEMBL377612
(2r)-2-phenyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile
(-)-prunasin
(-)-(2r)-prunasin
AKOS032948360
(r)-2-phenyl-2-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)acetonitrile
Q7253027
DTXSID001018995
F82086
AS-75874
CS-0017097
HY-N1548

Research Excerpts

Overview

Prunasin is a cyanogenic glycoside known for its role in defense against herbivores and other plants.

ExcerptReferenceRelevance
"Prunasin is a cyanogenic glycoside known for its role in defense against herbivores and other plants."( Seasonal Changes Affect Root Prunasin Concentration in Prunus serotina and Override Species Interactions between P. serotina and Quercus petraea.
Bielinis, E; Bułaj, B; Mejza, I; Robakowski, P; Stachowiak, J, 2016
)
1.45

Effects

ExcerptReferenceRelevance
"Prunasin has biological properties such as anti-inflammation, but plant extraction and chemical synthesis are impractical."( Prunasin production using engineered Escherichia coli expressing UGT85A47 from Japanese apricot and UDP-glucose biosynthetic enzyme genes.
Asano, Y; Yamaguchi, T, 2018
)
2.64

Toxicity

ExcerptReferenceRelevance
" LD50 value was calculated to 560 mg/kg but good dose dependent result was not obtained."( Toxicity of D, L-mandelonitrile-beta-D-glucoside, "prulaurasin" in rat.
Haga, M; Sakata, K; Sakata, M; Yoshida, A; Yuasa, C, 1987
)
0.27

Bioavailability

The oral bioavailability of prunasin is approximately 50%. amygdalin is hardly absorbed unchanged.

ExcerptReferenceRelevance
" Relatively rapid absorption of the glucoside from the gastrointestinal tract was observed with the highest absorption rate of 53."( Toxicity of D, L-mandelonitrile-beta-D-glucoside, "prulaurasin" in rat.
Haga, M; Sakata, K; Sakata, M; Yoshida, A; Yuasa, C, 1987
)
0.27
" The oral bioavailability of prunasin is approximately 50%, whereas amygdalin is hardly absorbed unchanged."( The pharmacokinetics of prunasin, a metabolite of amygdalin.
Olling, M; Rauws, AG; Timmerman, A, 1982
)
0.86
" MX administration improved the bioavailability of amygdalin and prunasin."( Concurrent quantification and comparative pharmacokinetic analysis of bioactive compounds in the Herba Ephedrae-Semen Armeniacae Amarum herb pair.
Chen, F; Luo, J; Ma, Q; Ren, M; Song, S; Tang, Q; Xie, Y; Xing, X, 2015
)
0.65

Dosage Studied

ExcerptRelevanceReference
" Blood cyanide concentrations following amygdalin treatment reached their highest level (130 nmol/ml) 1 hr after dosing and remained elevated until 3 hr after treatment."( Comparative metabolism of linamarin and amygdalin in hamsters.
Frakes, RA; Sharma, RP; Willhite, CC, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
prunasin
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
amygdalin and prunasin degradation09
prunasin and amygdalin biosynthesis015
amygdalin and prunasin degradation011
prunasin and amygdalin biosynthesis115

Bioassays (2)

Assay IDTitleYearJournalArticle
AID597947Antioxidant activity assessed as DPPH radical scavenging activity after 10 mins2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
Monoterpenoids from the aerial parts of Aruncus dioicus var. kamtschaticus and their antioxidant and cytotoxic activities.
AID597946Cytotoxicity against human Jurkat T cells after 36 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
Monoterpenoids from the aerial parts of Aruncus dioicus var. kamtschaticus and their antioxidant and cytotoxic activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (15.38)18.7374
1990's8 (15.38)18.2507
2000's17 (32.69)29.6817
2010's14 (26.92)24.3611
2020's5 (9.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.51 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index55.70 (26.88)
Search Engine Supply Index2.09 (0.95)

This Compound (38.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.79%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (3.57%)4.05%
Observational0 (0.00%)0.25%
Other53 (94.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]